Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Century Therapeutics (IPSC) Invested Capital (2022 - 2025)

Historic Invested Capital for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $184.7 million.

  • Century Therapeutics' Invested Capital fell 562.13% to $184.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $184.7 million, marking a year-over-year decrease of 562.13%. This contributed to the annual value of $161.4 million for FY2024, which is 1265.93% down from last year.
  • According to the latest figures from Q3 2025, Century Therapeutics' Invested Capital is $184.7 million, which was down 562.13% from $209.9 million recorded in Q2 2025.
  • Century Therapeutics' Invested Capital's 5-year high stood at $386.7 million during Q1 2022, with a 5-year trough of $161.4 million in Q4 2024.
  • For the 4-year period, Century Therapeutics' Invested Capital averaged around $248.1 million, with its median value being $222.1 million (2024).
  • Per our database at Business Quant, Century Therapeutics' Invested Capital plummeted by 4025.68% in 2023 and then surged by 3516.69% in 2025.
  • Century Therapeutics' Invested Capital (Quarter) stood at $309.2 million in 2022, then plummeted by 40.26% to $184.8 million in 2023, then fell by 12.66% to $161.4 million in 2024, then rose by 14.45% to $184.7 million in 2025.
  • Its last three reported values are $184.7 million in Q3 2025, $209.9 million for Q2 2025, and $240.4 million during Q1 2025.